スポンサーリンク
The Institute Of Medical Science The University Of Tokyo | 論文
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Attractive tools for systematic case accumulation